HCC O‐23: Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|13-14

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transarterial Chemoembolisation Using Doxorubicin Beads for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 5-6

Karger

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 4-10

Karger

Access to resources Recommend Favorite

Multimodal Treatment of Hepatocellular Carcinoma (HCC)

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 294-303

Karger

Access to resources Recommend Favorite